References
- Mosher WD, Martinez GM, Chandra A, et al. Use of contraception and use of family planning services in the United States: 1982-2002. Adv Data. 2004:1–36.
- Blanco-Molina Á, Monreal M. Venous thromboembolism in women taking hormonal contraceptives. Expert Rev Cardiovasc Ther. 2010;8(2):211–215.
- Cibula D, Gompel A, Mueck AO, et al. Hormonal contraception and risk of cancer. Hum Reprod Update. 2010;16(6):631–650.
- Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception. 2010;82(3):221–229.
- Bast RC, Brewer M, Zou C, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007;174:91–100.
- Vercellini P, Eskenazi B, Consonni D, et al. Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(2):159–170.
- Scholes D, Hubbard RA, Ichikawa LE, et al. Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuation. J Clin Endocrinol Metab. 2011;96(9):E1380–7.
- Young NR, Baker HW, Liu G, et al. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception. J Clin Endocrinol Metab. 1993;77(4):1028–1032.
- Griggs RC, Kingston W, Jozefowicz RF, et al. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol. 1989;66(1):498–503.
- Smith GI, Yoshino J, Reeds DN, et al. Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women. J Clin Endocrinol Metab. 2014;99(1):256–265.
- Kambadur R, Sharma M, Smith TP, et al. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 1997;7(9):910–916.
- Wallner C, Jaurich H, Wagner JM, et al. Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2. Sci Rep. 2017;7(1):9878.
- Wallner C, Drysch M, Becerikli M, et al. Interaction with the GDF8/11 pathway reveals treatment options for adenocarcinoma of the breast. Breast. 2018;37:134–141.
- Siriett V, Salerno MS, Berry C, et al. Antagonism of myostatin enhances muscle regeneration during sarcopenia. Mol Ther. 2007;15(8):1463–1470.
- Brenner PF, Goebelsmann U, Stanczyk FZ, et al. Serum levels of ethinylestradiol following its ingestion alone or in oral contraceptive formulations. Contraception. 1980;22(1):85–95.
- Stanczyk FZ. Structure –Function Relationships, Pharmacokinetics, and Potency of Orally and Parenterally Administered Progestogens. Treat. Postmenopausal Woman. Elsevier; 2007. p. 779–798.
- Retamales A, Zuloaga R, Valenzuela CA, et al. Insulin-like growth factor-1 suppresses the Myostatin signaling pathway during myogenic differentiation. Biochem Biophys Res Commun. 2015;464(2):596–602.
- Wallner C, Wagner JM, Dittfeld S, et al. Myostatin serum concentration as an indicator for deviated muscle metabolism in severe burn injuries. Scand J Surg. 2018.
- Benny Klimek ME, Aydogdu T, Link MJ, et al. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem Biophys Res Commun. 2010;391(3):1548–1554.
- Davis AJ, Brooks CF, Johnson PA. Estradiol regulation of follistatin and inhibin alpha- and beta(B)-subunit mRNA in avian granulosa cells . Gen Comp Endocrinol. 2000;119(3):308–316.
- Jasuja R, Costello JC, Singh R, et al. Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapy. Aging Cell. 2014;13(2):303–310.
- Braga M, Bhasin S, Jasuja R, et al. Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol. 2012;350(1):39–52.
- Wu Y, Qu J, Li H, et al. Relationship between serum level of growth differentiation factors 8, 11 and bone mineral density in girls with anorexia nervosa. Clin Endocrinol. 2019;90(1):88–93.
- Rabe T, Bohlmann MK, Rehberger-Schneider S, et al. Induction of estrogen receptor-alpha and -beta activities by synthetic progestins. Gynecol Endocrinol. 2000;14(2):118–126.
- Wallner C, Huber J, Drysch M, et al. Myostatin upregulation in patients in the chronic phase of severe burn injury leads to muscle cell catabolism. Eur Surg Res. 2019;60(1–2):86–96.
- Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001;233(4):556–564.
- Dittmar M. Comparison of soft tissue body composition in postmenopausal women with or without hormone replacement therapy considering the influence of reproductive history and lifestyle. Ann Hum Biol. 2001;28(2):207–221.
- Suuronen J, Sjöblom S, Tuppurainen M, et al. Effects of ethinyl estradiol-containing oral contraception and other factors on body composition and muscle strength among young healthy females in Finland—A cross-sectional study. Eur J Obstet Gynecol Reprod Biol. 2019;232:75–81.